Proton magnetic resonance spectroscopic imaging to differentiate between nonneoplastic lesions and brain tumors in children

Journal of Magnetic Resonance Imaging

Volumn 23, Issue 2, 2006, Pages 99-107

  Hourani, Roula ^a   Horská, Alena ^a   Albayram, Sait ^a   Brant, Larry J ^b   Melhem, Elias ^c   Cohen, Kenneth J ^d   Burger, Peter C ^e   Weingart, John D ^f   Carson, Benjamin ^f   Wharam, Moody D ^d   Barker, Peter B ^a,g  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f JOHNS HOPKINS HOSPITAL   (United States)

^g KENNEDY KRIEGER INSTITUTE   (United States)

Author keywords

Brain; Choline; Creatine; N acetyl aspartate; Pediatric tumors; Proton MRSI

Indexed keywords

CHOLINE; CONTRAST MEDIUM; CREATINE; GADOLINIUM PENTETATE; N ACETYLASPARTIC ACID; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT;

ADOLESCENT; ARTICLE; ASTROCYTOMA; BENIGN TUMOR; BRAIN METABOLISM; BRAIN TUMOR; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; GLIOMA; HAMARTOMA; HUMAN; IMAGE QUALITY; MALE; MEDULLOBLASTOMA; NEUROIMAGING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TUMOR DIAGNOSIS; XANTHOMA;

ADOLESCENT; ASTROCYTOMA; BIOPSY, NEEDLE; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; GERMINOMA; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE SPECTROSCOPY; MALE; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 31944445417     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.20480     Document Type: Article

References (39)

1. Tzika AA, Zarifi MK, Goumnerova L, et al. Neuroimaging in pediatric brain tumors; Gd-DTPA-enhanced, hemodynamic, and diffusion MR imaging compared with MR spectroscopic imaging. AJNR Am J Neuroradiol 2002;23:322-333.
2. Bernstein M, Parrent AG. Complications of CT-guided stereotactic biopsy of intra-axial brain lesions. J Neurosurg 1994;81:165-168.
3. Yu X, Liu Z, Tian Z, et al. Stereotactic biopsy for intracranial space-occupying lesions: clinical analysis of 550 cases. Stereotact Fund Neurosurg 2000;75:103-108.
4. Taylor JS, Ogg RJ, Langston JW. Proton MR spectroscopy of pediatric brain tumors. Neuroimaging Clin N Am 1998;8:753-779.
5. Speck O, Thiel T, Hennig J. Grading and therapy monitoring of astrocytomas with 1H-spectroscopy: preliminary study. Anticancer Res 1996;16:1581-1585.
6. Zakrzewski K, Kubicki M, Polis L, Nowoslawska E, Liberski PP. Proton magnetic resonance spectroscopy of primary pediatric brain tumors: neuropathological correlation. Folia Neuropathol 1999;37:148-151.
7. Barker PB. N-acetyl aspartate - a neuronal marker? Ann Neurol 2001;49:423-424.
8. Rand SD, Prost R, Haughton V, et al. Accuracy of single-voxel proton MR spectroscopy in distinguishing neoplastic from nonneoplastic brain lesions. AJNR Am J Neuroradiol 1997;18:1695-1704.
9. Krouwer HG, Kim TA, Rand SD, et al. Single-voxel proton MR spectroscopy of nonneoplastic brain lesions suggestive of a neoplasm. AJNR Am J Neuroradiol 1998;19:1695-1703.
10. Moller-Hartmann W, Herminghaus S, Krings T, et al. Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions. Neuroradiology 2002;44:371-381.
11. Poptani H, Kaartinen J, Gupta RK, Niemitz M, Hiltunen Y, Kauppinen RA. Diagnostic assessment of brain tumours and non-neoplastic brain disorders in vivo using proton nuclear magnetic resonance spectroscopy and artificial neural networks. J Cancer Res Clin Oncol 1999;125:343-349.
12. Duyn JH, Gillen J, Sobering G, van Zijl PC, Moonen CT. Multisection proton MR spectroscopic imaging of the brain. Radiology 1993;188:277-282.
13. Barker PB, Szopinski K, Horska A. Metabolic heterogeneity at the level of the anterior and posterior commissures. Magn Reson Med 2000;43:348-354.
14. Sutton LN, Wang Z, Gusnard D. et al. Proton magnetic resonance spectroscopy of pediatric brain tumors. Neurosurgery 1992;31:195-202.
15. Tzika AA, Vigneron DB, Dunn RS, Nelson SJ, Ball Jr WS. Intracranial tumors in children: small single-voxel proton MR spectroscopy using short- and long-echo sequences. Neuroradiology 1996;38:254-263.
16. Lazareff JA, Gupta RK, Alger J. Variation of post-treatment H-MRSI choline intensity in pediatric gliomas. J Neurooncol 1999;41:291-298.
17. Tzika AA, Zurakowski D, Poussaint TY, et al. Proton magnetic spectroscopic imaging of the child's brain: the response of tumors to treatment. Neuroradiology 2001;43:169-177.
18. Vaidya SJ, Payne GS, Leach MO, Pinkerton CR. Potential role of magnetic resonance spectroscopy in assessment of tumour response in childhood cancer. Eur J Cancer 2003;39:728-735.
19. Taylor JS, Langston JW, Reddick WE, et al. Clinical value of proton magnetic resonance spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosis. Int J Radiat Oncol Biol Phys 1996;36:1251-1261.
20. Tzika AA, Vajapeyam S, Barnes PD. Multivoxel proton MR spectroscopy and hemodynamic MR imaging of childhood brain tumors: preliminary observations. AJNR Am J Neuroradiol 1997;18:203-218.
21. Wald LL, Nelson SJ, Day MR, et al. Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy. J Neurosurg 1997;87:525-534.
22. Girard N, Wang ZJ, Erbetta A, et al. Prognostic value of proton MR spectroscopy of cerebral hemisphere tumors in children. Neuroradiology 1998;40:121-125.
23. Lazareff JA, Bockhorst KH, Curran J, Olmstead C, Alger JR. Pediatric low-grade gliomas: prognosis with proton magnetic resonance spectroscopic imaging. Neurosurgery 1998;43:809-817; discussion 817-808.
24. Warren KE, Frank JA, Black JL, et al. Proton magnetic resonance spectroscopic Imaging in children with recurrent primary brain tumors. J Clin Oncol 2000;18:1020-1026.
25. Saindane AM, Cha S, Law M, Xue X, Knopp EA, Zagzag D. Proton MR spectroscopy of tumefactive demyelinating lesions. AJNR Am J Neuroradiol 2002;23:1378-1386.
26. Cecil KM, Jones BV. Magnetic resonance spectroscopy of the pediatric brain. Top Magn Reson Imaging 2001;12:435-452.
27. Grossman RI, Lenkinski RE, Ramer KN, Gonzalez-Scarano F, Cohen JA. MR proton spectroscopy in multiple sclerosis. AJNR Am J Neuroradiol 1992;13:1535-1543.
28. Bitsch A, Bruhn H, Vougioukas V, et al. Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. AJNR Am J Neuroradiol 1999;20:1619-1627.
29. Brenner RE, Munro PM, Williams SC, et al. The proton NMR spectrum in acute EAE: the significance of the change in the Cho:Cr ratio. Magn Reson Med 1993;29:737-745.
30. De Stefano N, Caramanos Z, Preul MC, Francis G, Antel JP. Arnold DL. In vivo differentiation of astrocytic brain tumors and isolated demyelinating lesions of the type seen in multiple sclerosis using 1H magnetic resonance spectroscopic imaging. Ann Neurol 1998;44:273-278.
31. Tzika AA, Astrakas LG, Zarifl MK, et al. Multiparametric MR assessment of pediatric brain tumors. Neuroradiology 2003;45:1-10.
32. Tong Z, Yamaki T, Harada K, Houkin K. In vivo quantification of the metabolites in normal brain and brain tumors by proton MR spectroscopy using water as an internal standard. Magn Reson Imaging 2004;22:1017-1024.
33. Wang Z, Sutton LN, Cnaan A, et al. Proton MR spectroscopy of pediatric cerebellar tumors. AJNR Am J Neuroradiol 1995;16:1821-1833.
34. Hwang JH, Egnaczyk GF, Ballard E, Dunn RS, Holland SK, Ball Jr WS. Proton MR spectroscopic characteristics of pediatric pilocytic astrocytomas. AJNRAm J Neuroradiol 1998;19:535-540.
35. Shukla-Dave A, Gupta RK, Roy R, et al. Prospective evaluation of in vivo proton MR spectroscopy in differentiation of similar appearing intracranial cystic lesions. Magn Reson Imaging 2001;19:103-110.
36. Pouwels PJ, Brockmann K, Kruse B, et al. Regional age dependence of human brain metabolites from infancy to adulthood as detected by quantitative localized proton MRS. Pediatr Res 1999;46:474-485.
37. Horska A, Kaufmann WE, Brant LJ, Naidu S, Harris JC, Barker PB. In vivo quantitative proton MRSI study of brain development from childhood to adolescence. J Magn Reson Imaging 2002;15:137-143.
38. Lazareff JA, Olmstead C, Bockhorst KH, Alger JR. Proton magnetic resonance spectroscopic imaging of pediatric low-grade astrocytomas. Childs Nerv Syst 1996;12:130-135.
39. Golay X, Gillen J, van Zijl PC, Barker PB. Scan time reduction in proton magnetic resonance spectroscopic imaging of the human brain. Magn Reson Med 2002;47:384-387.